NL-OMON21350招募中不适用
Mesenchymal stromal cells for treatment of drug resistantpediatric juvenile idiopathic arthritis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •Patients (4-18 years of age) diagnosed with juvenile idiopathic arthritis according to the ILAR-criteria with active arthritis resistant to intra-articular steroids and systemic use of methotrexate and for whom no on-label indication exists for (not yet used) biologicals.
排除标准
- •Concurrent use of biological response modifiers.
- •Concurrent infection, febrile illness or malignancy.
研究者
相似试验
进行中（未招募）
不适用
Adult bonemarrow stem cells for treatment of juvenile arthritis in childhoodjuvenile idiopathic arthritisEUCTR2012-002067-10-NLniversity Medical Center Utrecht
进行中（未招募）
不适用
Mesenchymal Stromal Cells (MSC) for the treatment of severe (grade II-IV) steroid-resistant Graft Versus Host Disease (GVHD): a phase I trial - MSC-GvHDGraft versus Host disease GvHD steroid resistantEUCTR2008-007869-23-ITAZIENDA OSPEDALIERA SAN GERARDO DI MONZA
进行中（未招募）
不适用
se of mesenchymal cells for the treatment of patients with respiratory syndrome caused by new coronavirusRBR-3fz9yrPaulo Roberto Slud Brofman
进行中（未招募）
不适用
Mesenchymal stem cell based therapy for the treatment of osteogenesis imperfectaOsteogenesis imperfecta (OI) is a rare genetic disorder with increased bone fragility of varying severity. In the majority of patients the disease is caused by mutations in collagen type I. Severe OI is characterized by osteopenia, frequent fractures, progressive deformity, short stature, loss of mobility, chronic pain and can lead to premature death. At present a cure does not exist.EUCTR2012-002553-38-ESItziar Astigarraga Aguirre
终止
1 期
se of mesenchymal stromal cells for Graft-versus-host disease after stem cell transplantatioGraft vs Host DiseaseT86.0RBR-7s99ksfHospital de Clínicas da Universidade Federal do Paraná - HCUFPR